手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按作者
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
4条
与
Z. Cui
有关的结果
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis
2021年 发布于
Andrologia
53卷 第9期
Chai
Y. Zhou
Z. Cui
Y. Che
X. Zhang
Y.
Aged
Humans
*Lower Urinary Tract Symptoms
Male
Naphthalenes
Piperazines
Prospective Studies
*Prostatic Hyperplasia
Quality of Life
Sulfonamides
Tamsulosin
Treatment Outcome
benign prostatic hyperplasia
lower urinary tract symptoms
naftopidil
tamsulosin
文献简介
原文链接
Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials
2020年 发布于
Exp Ther Med
20卷 第2期
Zhou
Z. Cui
Y. Wu
J. Jin
H.
benign prostatic hyperplasia
dutasteride
finasteride
meta-analysis
randomized controlled trials
文献简介
原文链接
Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction
2019年 发布于
Am J Mens Health
13卷 第5期
Zhou
Z. Zheng
X. Wu
J. Gao
Z. Xu
Z. Cui
Y.
Aged
Drug Therapy
Combination
Erectile Dysfunction/*drug therapy
Humans
Male
Middle Aged
Phosphodiesterase Inhibitors
Prostatic Hyperplasia/*drug therapy
Tadalafil
Tamsulosin
Treatment Outcome
Vasodilator Agents
*benign prostatic hyperplasia
*erectile dysfunction
*meta-analysis
*tadalafil
*tamsulosin
conflicts of interest with respect to the research
authorship
and/or
publication of this article.
文献简介
原文链接
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
2019年 发布于
BMC Urol
19卷 第1期
Zhou
Z. Cui
Y. Wu
J. Ding
R. Cai
T. Gao
Z.
5-alpha Reductase Inhibitors/*administration & dosage
Adrenergic alpha-1 Receptor Antagonists/*administration & dosage
Drug Therapy
Combination
Dutasteride/*administration & dosage
Erectile Dysfunction/chemically induced/diagnosis
Humans
Male
Prostatic Hyperplasia/diagnosis/*drug therapy/epidemiology
Randomized Controlled Trials as Topic/methods
Tamsulosin/*administration & dosage
Treatment Outcome
Benign prostatic hyperplasia
Dutasteride
Meta-analysis
Randomized controlled trials
Tamsulosin
published studies
thus no ethical approval and patient consent are required.
CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare
that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains
neutral with regard to jurisdictional claims in published maps and institutional
affiliations.
文献简介
原文链接